Sorry, your browser is out of date. To view this page correctly, please install a modern browser (Microsoft Edge, Firefox or Google Chrome).
SAI - Detailed view
Please log in as a company employee using your SIMIS-Login. For further information please see the FAQ.
SPEVIGO Inf Konz 450 mg/7.5ml 2 Durchstf 7.5 ml
Drug
Spevigo, Konzentrat zur Herstellung einer Infusionslösung
Generalisierte pustulöse Psoriasis
07.15.0. – immunosuppressants
HAM – Human medicine
KOINF – Concentrate for solution for infusion
BT – biological medicines
A – Dispensed once only on prescription by a physician or veterinarian (A)
B – limited
8/9/2023
10/21/2027
Dosage strength
Spevigo 450 mg/7,5 ml (60 mg/ml) , Konzentrat zur Herstellung einer Infusionslösung
Generalisierte pustulöse Psoriasis
01
B – limited
Package
7680686250017
In trade from / since 8/9/2023
A/R – Authorised / referenced
2 vial(s)
001
B – limited
Declaration
Component
450 mg spesolimabum
natrii acetas trihydricus
acidum aceticum glaciale
386 mg saccharum
arginini hydrochloridum
polysorbatum 20
aqua ad iniectabile
6.8 mg natrium
acidum aceticum glaciale
386 mg saccharum
arginini hydrochloridum
polysorbatum 20
aqua ad iniectabile
6.8 mg natrium
Spezialitätenliste***
SL
-
-
16349.85
None
Yes
10%
No
Authorisation holder
7601001001022
Leo Pharmaceutical Products Sarath Ltd.
8302 Kloten (ZH)
8302 Kloten (ZH)
Date of revision of the text
4/1/2026
Please log in as a company employee using your SIMIS-Login. For further information please see the FAQ.
Data source: Swissmedic, *authorisation holder, **Refdata foundation, ***FOPH.